SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aspira Pathlab & Diagnostics informs about scrutinizer’s report and voting results

12 Sep 2022 Evaluate

Aspira Pathlab & Diagnostics has informed that the 49th Annual General Meeting (‘AGM’) of the Company was held on Saturday, September 10, 2022 at 11:30 am through Video Conference in compliance with the provisions of Companies Act, 2013 & circulars issued by Ministry of Corporate Affairs in this behalf. In this regard, the company has enclosed the following: Scrutinizer's Report dated September 12, 2022 pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014 and Voting results of remote e-voting and e-voting during AGM, pursuant to regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

59.35 1.15 (1.98%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×